Few of the record 143 biotech startups that made their public debut last year had a product to sell. We unpack the odd nature of biotech IPOs.
Health, Wellness & Biotech
While there are plenty of startups in the drug manufacturing world, very few (if any) have been able to approach the problem through designing...
This time last year, a startup would have needed to raise $100 million to make this list—those days are long gone. Nevertheless, the market is strong...
Increasingly, startup entrepreneurs and investors are diving into the burgeoning "famtech" sector.
Biotech upstart Tempus announced on Thursday it raised $275 million through equity from previous investors and debt financing from Ares Management...
Twelve companies joined The Crunchbase Unicorn Board in September 2022, adding $19.6 billion in value to the board.
This brings total financing for the company to more than $150 million, according to the company
Drug development is a slow, capital-intensive process. However, over $70 billion has poured into the space so far this year alone.
Treeline Biosciences has raised around $473 million in total, according to STAT News’ reporting on SEC filings.
Last week it seemed like big rounds were making a comeback. That’s not the case this week, as even the largest rounds were on the small side and...
Pleno, a San Diego-based startup aimed at speeding up disease diagnosis and treatment, announced on Wednesday it raised $40 million in Series A...
![Illustration of toast with $ toasted in. [Dom Guzman]](https://news.crunchbase.com/wp-content/uploads/Forecast-dollar-sign-300x168.jpg)
67.1K Followers